You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Persistent Endometrial Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Recurrent Trial in Tainan (Crizotinib 250 MG)

Recruiting
  • Endometrial Cancer Recurrent
  • Crizotinib 250 MG
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Jun 6, 2022

Endometrial Cancer, Recurrent Endometrial Cancer Trial in United States (LY3023414)

Completed
  • Endometrial Cancer
  • Recurrent Endometrial Cancer
  • Basking Ridge, New Jersey
  • +5 more
Sep 13, 2022

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Nov 21, 2022

Endometrial Cancer Trial in Boston, Worcester (Pembrolizumab, IMGN853)

Recruiting
  • Endometrial Cancer
  • Boston, Massachusetts
  • +2 more
Oct 24, 2022

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Endometrial Cancer Trial in New Haven (IMGN853)

Recruiting
  • Endometrial Cancer
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 10, 2022

Endometrial Cancer, Endometrial Carcinosarcoma, Endometrial Carcinoma Trial in United States (Durvalumab, Tremelimumab)

Completed
  • Endometrial Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

Active, not recruiting
  • Endometrial Adenocarcinoma
  • Endometrial Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Nov 29, 2021

Endometrial Carcinoma Trial in New Haven (Sacituzumab Govitecan)

Recruiting
  • Endometrial Carcinoma
  • Sacituzumab Govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Apr 4, 2022

Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)

Not yet recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2023

Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in

Completed
Has Results
  • Endometrial Endometrioid Adenocarcinoma
  • +5 more
  • New Haven, Connecticut
  • +42 more
Jan 25, 2022

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in United States

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Hartford, Connecticut
  • +21 more
Oct 13, 2020

Advanced, Persistent, or Recurrent Endometrial Cancer Trial in United States (Everolimus, Tamoxifen, Letrozole)

Active, not recruiting
Has Results
  • Advanced, Persistent, or Recurrent Endometrial Cancer
  • Aurora, Colorado
  • +25 more
Sep 28, 2021

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Cancer Screening Trial (transvaginal ultrasound and microscale endometrial sampling biopsy)

Not yet recruiting
  • Cancer Screening
  • transvaginal ultrasound and microscale endometrial sampling biopsy
  • (no location specified)
Nov 5, 2023

Revealing Engagement Patterns Among Endometrial Cancer Patients

Not yet recruiting
  • Endometrial Cancer
    • San Francisco, California
      Power Life Sciences
    Aug 11, 2023

    Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

    Not yet recruiting
    • Endometrial Cancer
    • +5 more
    • Oklahoma City, Oklahoma
      University Oklahoma Stephenson Cancer Center
    Aug 16, 2023

    Endometrial Cancer, Endometrial Tumors, Obesity, Morbid Trial (Robot-assisted surgery, Laparoscopic surgery)

    Not yet recruiting
    • Endometrial Cancer
    • +4 more
    • Robot-assisted surgery
    • Laparoscopic surgery
    • (no location specified)
    Jul 25, 2023

    Endometrial Changes in Breast Cancer Women.

    Active, not recruiting
    • Endometrial Cancer
    • +3 more
    • Hysteroscopy
    • Rome, Lazio, Italy
      IRCCS "Regina Elena" National Cancer Institute
    Jan 29, 2023

    Endometrial Cancer, Endometrial Adenocarcinoma Trial (Cadonilimab, Carboplatin, Cisplatin)

    Not yet recruiting
    • Endometrial Cancer
    • Endometrial Adenocarcinoma
    • (no location specified)
    Oct 7, 2023

    Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes Trial in New York

    Recruiting
    • Colorectal Cancer
    • +2 more
      • New York, New York
        NYP/Weill Cornell Medicine
      Oct 17, 2023

      Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

      Recruiting
      • Endometrial Cancer
      • low-depth whole-genome sequencing technology
      • Guangzhou, Guangdong, China
        The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Oct 9, 2023

      Predictors of Node Positivity in Endometrial Cancer

      Not yet recruiting
      • Endometrial Cancer
        • (no location specified)
        Mar 29, 2023

        Endometrial Cancer, Perioperative Complication, Prehabilitation Trial in Athens (Ferrous Gluconate 300 MG)

        Enrolling by invitation
        • Endometrial Cancer
        • +2 more
        • Ferrous Gluconate 300 MG
        • Athens, Greece
          First department of Obstetrics and Gynecology
        Sep 17, 2023

        Endometrial Cancer in Brazil

        Not yet recruiting
        • Endometrial Cancer
        • Observational study
        • (no location specified)
        Aug 23, 2023